Title : Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.

Pub. Date : 2011 Apr 18

PMID : 21533122






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We propose that CD20(+)CD5(+)sIgM(+) lymphocytes producing anti-carbohydrate antibodies with anti-tumor activity, might contribute to the response to imatinib treatment. Imatinib Mesylate keratin 20 Homo sapiens